Chairperson Independence is the apex governance test in any Indian listed company. SEBI LODR Reg 17(1B), Companies Act Section 149(6), Schedule IV, read together across five graduated layers. Titan Biotech FY25 — voluntary best-practice compliance: 14 board meetings, Independent Non-Executive Chair, ~₹3 Cr borrowings, 103% CFO/Operating-Profit ratio.